Aims: To examine the proportion of patients with thrombosis or surgical ligation of arteriovenous fistula (AVF) after kidney transplantation (TX) and to explore the time passed after the TX until the loss of AVF function. Patients and methods: The study design was historical cohort study. The study included all 123 patients (57.7 % men, median age 58 years, from 34 to 79) that underwent kidney TX in the University Hospital Centre Osijek during the first 10 years of practicing that kind of surgery in the hospital. The data on AVF function, thrombosis or ligation were undertaken from medical records, along with demographics (age, gender, time after TX). The data were presented descriptively and after statistical analysis that was performed using SPSS (version 17.0). Results: FunctionalAVF immediately prior to TX was found in 78 % of the patients. The AVF was still functional in 39.84 % of all patients for 3 years (median, interquartile range, IQR 0 -3) after TX. AVF thrombosis happened in 17.89 %, while surgical ligation was performed in 20.33 % of all patients. The most common reason for ligation was increased risk of heart failure (in 75 % of the ligations), followed by aneurysmatic dilatation and arm swelling. Median time after TX to thrombosis or ligation of AVF was 2 years, IQR 0 -3. Thrombosis or ligations were significantly more frequent in women. The outcome of AVF after kidney TX was not related to the patient's age. Conclusion: AVF after kidney TX often became nonfunctional, either after spontaneous thrombosis or after surgical ligation, which was required for increased heart failure risk in the majority of the cases.
introduction
The Arteriovenous Fistula (AVF) is a permanent vascular approach for patients with chronic kidney disease (CKD) in the form of a direct (subcutaneous compound between the radial artery and the cephalic vein on the forearm, but may be used and the blood vessels more proximal than the carpal joint or under the elbows) or of the indirect AVF (a compound between the artery and vein which is usually formed by a syntethic vascular implant), so-called. polytetrafluoroethylene graft (PTFE). The central venous catheter (CVC) is used in those patients who have exhausted other possibilities of permanent vascular access [1] [2] [3] [4] . CKD is defined as a reduction of renal glomerular filtration <60 ml / min / 1.73 m2 of body surface area for three or more months. Diabetic and hypertensive nephropathy, glomerulonephritis, and autosomal dominant polycystic kidney disease are the main causes of CKD appearing in developed countries such as the United States, but also in many underdeveloped countries 5, 6 . Clinical symptoms of the disease appear in the damage more than 80% of kidney function, or from the third stage of a disease. It manifests as anemia, weakness, fatigue, loss of appetite and nocturia. The final stage of the CKD is in fifth grade. Then there are various organic complications such as cardiovascular, digestive, neurological, hematological, endocrinological, etc. At this stage, life is unsustainable without replacing renal function by dialysis through previously created AVF or transplantation (TX) [7] [8] [9] [10] .
replacement of renal function Dialysis is the process of eliminating waste metabolites and excess water from the body. There are two methods of dialysis: hemodialysis (HD) and peritoneal dialysis (PD) 10 . HD is a procedure that removes blood from the body, and purified through a filter out of the body, called dialyzer, and require repeated access to the bloodstream. HD-blood of the patient flowing through the tube connected AVF and through a dialyzer. During HD, heparin is used, a medication that prevents blood clotting inside the dialyser. Inside the dialyzer, a porous membrane made of separated blood fluid (dialysate) which is chemically similar to normal body fluids. The pressure side of the membrane where the dialysate is less than that on the side of the blood, allowing the liquid, and waste products harmful compounds in the blood cross the (filtered) through the membrane into the dialysate. Blood cells and large proteins are too large to pass through the small membrane cavities. The dialyzed (purified) blood returns to the patient's body 10 . PD uses the peritoneum as a semipermeable membrane for the exchange of matter. It is based on pouring a solution containing electrolytes and glucose or icodextrin as the osmotic substances in the abdominal cavity, typically by gravity. Uremic toxins from the blood passes into the dialysate concentration gradient down the diffusion process, while the osmolality of dialysate determines migration of water. The tip of the catheter with numerous perforations is placed in a small pelvis and the outer part remains outside the abdominal cavity [1] [2] [3] [4] . TX is the best method of repleacing the renal function in the treatment of CKD. Often, a regular exacerbated renal function is achieved so that one transplanted kidney can completely replace the lost function of its own kidneys. Dialysis is usally necessary for the appropriate treatment and preparation of patients for TX and subsequent immunosuppression therapy, although TX can also be done without prior dialysis -so-called. preemptivni TX. Due to constant immune response to allograft kidney, lifetime is performed immunosuppressive therapy to prevent graft rejection [11] [12] [13] [14] [15] [16] [17] . There are several chiral access options for HD: AVF, then AV graft or CVC 18, 19 . In a study evaluating the quality of life in patients with AVF or AV graft, it was concluded that he was equal to or moderate 20 . However, due to the blood flow of about 400 ml / min required for high quality dialysis, high passage and low incidence of infection, AVF is a better choice compared to AV graft or CVC 18, 19 . It is most commonly used when kidney glomerular filtration is <15 ml / min / 1.73 m2 of body surface 21 . It is created by a short joining of the arteries with the vein located mostly on the proximal part of the upper arm (cervical vein and radial artery or basal vein and ulnar artery) 18, 19 . The maturity for successfully performing subcutaneous AVF puncture is reached when arterial venous arterialization occurs due to the constant artery blood vessel. The vein grows and becomes visible on the skin 22 . The AVF's maturity can also be stimulated by compressing the rubber ball. Then it becomes large enough to accept a large blood flow of about 400 ml / min required for successful dialysis. AVF, as such, becomes mature for its basic function 23 .
aVf complicationS
In recent years ischemic lesions that were caused by arterial phenomenon of "steal", have become more common in the elderly population with high morbidity accompanying vascular disease and diabetes patients. There are two forms of this phenomenon. The first is associated with the rapid flow in which AVF with very low resistance begins to "suck" the blood from the palmar arch and ulnar artery, creating a critical ischemia of the fingers. In theory, this type of lesion is relatively easily corrected by limiting the size of anastomosis and reducing the flow of fistula 24, 25 . Since resistance goes with the fourth potency of the radius according to Poiseuill's law, only a drastic reduction of the lumen of the fistula will be effective. However, creating an effective and safe lumen is difficult and it poses a risk of low flow and possible thrombosis. Harder, but unfortunately increasing frequency, is another form of the "steal" phenomenom and that in patients with low blood flow through the AVF. This form is primarily a result of stenosis of peripheral arteries, so even normal blood flow through the fistula will create a critical ischemia in the distal vascular pool. Preoperative monitoring helps to predict the risk of a potential low flow "steal" phenomena from the limited vasodilation of the palmar arch arteries, which is manifested by abnormally low postishemic diastolic flow after fingers pressing. There are several treatment options to eliminate this problem. One is to close the fistula and use CVC, and the alternative procedure was originally proposed by Schanzer et al. and has recently been renamed DRIL (distal revascularization-interval ligation, closure of distal part of revascularization) 26, 27 . Cardiovascular diseases are the main cause of death in dialysis patients or patients with kidney transplants. In the case of renal TX, the AVF is left open because it is unknown how long it will take for a satisfactory kidney function to last. It is closed by ligation only in the case of cardiac failure, rapid blood flow through the fistula, complications at the entrance to the fistula itself or in case of aesthetic reasons. In the case of ligation, fistula loss occurs and can not be re-opened in case of repeated HD needs. Ligation is more common with fistulas on the upper arm because of the faster blood flow. Fast flow through AVF, greater than 2200 ml/min results in Original Article
8-14
increased cardiac output, followed by cardiac failure, hypertrophy or left ventricular dilatation, increased diastolic pressure, pulmonary hypertension, cardiomegaly, distal ischemia, aneurysmatic enlargement etc. [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . Rapid blood flow leads to damage to the AVF's blood vessel endothelium, which favors the development of inflammatory activity. This results in the accumulation of inflammatory mediators such as interleukin 2, interleukin 6, tumor necrosis factor alpha and C-reactive protein. They exacerbate the onset of heart failure and lead to an increase in mortality in hemodialysis patients [38] [39] [40] [41] [42] [43] [44] . AVF aneurysms usually result from the destruction of the blood vessels wall and the replacement of the biophysically less valuable collagen tissue. Once aneurysm occurs, Laplace's law predicts a spontaneous tendency of progression, because pressure applied to the walls of blood vessels becomes larger with an increased diameter of the aneurysm. The prerequisite for creating aneurysm is usually stenosis and prolonged increase in blood flow pressure. The main complications of aneurysm are rupture, infection (resulting from intraaneurysmatic thrombi), and in rare cases anterograde or retrograde emboli 45 . In addition to the AVF's surgical closure, spontaneous occlusion or thrombosis may occur in the arteries, anastomoses themselves, or usually veins. The most common cause of AVF occlusion is the diameter of the cephalic vein and radial artery. The smaller it is, the greater the risk of occlusion. In addition, high blood pressure and high levels of parathyroid hormone also increase the risk of occlusion. Occlusion can also be due to intimal hyperplasia of blood vessels during the anastomotic surgical procedure 46, 47 . Thrombosis can be caused by stenosis itself, wearing inappropriate clothing, and aneurysmatic enlargement, causing turbulent blood flow, arterial blood supply and arterial hypotension. Pathophysiology based on stenosis is a blood flow turbulence that activates platelets and endothelial cells. In this context, the role of platelet growth factor 48 was also determined. The final trigger that causes thrombosis is critical reduction of blood flow through the fistula. Many studies prove that low flow through AVF best predictor of thrombosis. The critical flow rate is different in PTFE grafts and AV fistulas. Fistulas that are most susceptible to thrombosis are those with a flow rate <200 ml / min. This is far less than what is needed for optimal blood flow during dialysis. As a result of low blood flow, dialysis will become ineffective and will result in recirculation 49 . Several procedures help identify critical low blood flow and upcoming stenosis: auscultation (high frequency noise at the site of stenosis), hand lift examination (collapse of poststenotic vein segment and permanent congestion of the prestenotic segment), prolonged bleeding after removal of the needle from the injection site and increased pressure in the venous supply during HD, particularly over a number of consecutive dialysis 50 . Central venous stenosis may be clinically asymptomatic before the creation of vascular access and become symptomatic only when the flow increases. If critical stenosis can not accommodate the increased flow rate, the result will be a run-off hands and cyanosis, as well as the creation of collateral in the wall of the chest. Stenosis of the central vein is typically the result of previous subclavian catheter, or may be the result of incorporation of a pacemaker and its wire, then primary thrombosis in patients with antiphospholipid antibodies and coagulation disorders, tumors pressure etc. One therapeutic option is to ligate anastomosis and use a second arm after a corresponding X-ray image to exclude bilateral stenosis [51] [52] [53] [54] [55] [56] .
HypotHeSiS and aim
The hypothesis reads: "Arteriovenous fistula after renal transplantation often become non-functional or require ligation." The aims of this study are to investigate the proportion of kidney transplanted subjects with spontaneous thrombosis, planar "closure" of AVF (ligation) after TX, and the remaining proportion of AVFs still functional. Then investigate time after TX where there was a possible loss of AVF function, and finally determine the relationship between these outcomes of AVF with demographic characteristics of respondents (age, sex, time after TX).
Methods
The study is structured as a cohort historical research. 
StatiStical procedureS
The data are presented descriptively and processed analytically. Nominal data are presented using absolute and relative frequencies.
The numerical data are presented as medians and interquartile range. The distribution normality was tested by Kolmogorov-Smirnov test. Frequency differences were measured by the hi-squared test in the numerical variables of the asymmetric distribution with the Kruskal-Wallis test. Statistical significance was accepted at P <0.05. Statistical analysis was performed using SPSS software (version 17.0).
results
The study was conducted on 123 patients, of whom 71 (57.7%) were men and 52 (42.3%) women. Functional AVF, just before TX, had 96 (78%) patients, 77 (80.2%) on the left hand. AVF after TX is currently functioning in 49 patients (39.8% of all and 51% of patients with functional AVF just prior to TX) (median follow-up 3 years, interquartile range (IQR) 1-5, from 0 to 10). AVF thrombosis had, at some point after TX, 22 (17.9% of all) patients (21.9% of those with functional AVF immediately before TX), and 25 (20.3 % of all, or 26% of those who had functional AVF just prior to TX). The most common cause of ligation was (for 18 patients, 75% who had ligation) cardiac overload (Table 1) . Glomerulonephritis and autosomal dominant polycystic kidney disease were the two most common causes of renal failure in transplant patients. These are followed by interstitial nephritis, diabetes, arterial hypertension and others (malignant disease, urinary abnormalities, vasculitis) ( Table 2) The time to thrombosis or ligation of AVF was median 2 years (IQR 0 -3). The median age at TX was 52 years (IQR 47-58) ranging from 27 to 70 years ( Table 3 ). The median age of all patients was 58 years, ranging from 34 to 79. Twelve patients (9.8%) had 2 or more renal TX-a. AVF is curently functioning Original Article
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in 49 (39.84 %) patients (Picture 1). In the post-transplant period until the time of this study, 13 (10.6%) respondents died, most often due to a heart attack (4 patients, 3.3%). Graft works or the patient died with a functioning graft in 107 (87%) patients. Graft does not work or the patient died with graft by failed in 16 (13%) patients. The patient is alive and graft works in 96 (78%) patients. The patient is not alive or is not functioning graft in 27 (22%) patients. (Table 4 ). The fate of AVF significantly differed between men and women, so women had more often AVF thrombosis or ligation (χ2 = 7,948, P = 0.047). In most women who had a functional AVF (36 out of 52) immediately before TX, there was a thrombosis (in 9) or AVF was ligated (in 13). In 60 out of 71 men AVF was functional just before TX, 13 of them was thrombosed and in 12 was ligated. Patients did not differ in age from AVF fate (P = 0.76, Kruskal-Wallis test).
diScuSSion
In our study of 123 patients with kidney transplant, AVF is currently functioning in 39.84% of patients (median follow-up 3 years), AVF thrombosis at some point after TX had 17.89% of patients, and their ligation 20.33%. The most common cause of AVF ligation in our study was heart overload, for 18 patients (75% of those who had a ligation). AVF after the renal TX has, therefore, often become dysfunctional, spontaneous or surgically closed.
In the research of Schier et al. there were 113 patients involved. In most patients it was necessary to close the AVF because of the onset of symptoms of heart overload, which corresponds to our results, which, in their study were caused by the rapid flow of blood through the AVF 59 . Since the blood flow is faster through the AVF, which are on the upper arms but the forearms 60 , so is the "closure" of AVF in the research of Schier et al. more often in those patients with AVFs on the upper arms.We do not have information on the exact localization of the AVF on hand for our patients and no data on the flow rate through the AVF. Vascular surgeons did not want to do the AVF ligation if there were no pathological findings in echocardiography in these patients, and the most common pathological findings on echocardiography were pulmonary hypertension and right ventricular dilatation 59 . Echocardiographic data for our patients were also not available.The assessment of cardiac load was mostly clinical. This and our research shows that the need to close AVF in patients with kidney stones is not uncommon 59 62 .
In our study, the median time spent on dialysis was 3 years and 9.8% of patients had two or more TXs. In a study by Schier et al. the median time spent on dialysis was 3 years and 6 months, and 21.2% of patients had two or more TXs. Accordingly, no correlation was found between the number of TXs in patients and the number of AVF ligation, as well as a correlation between the time spent on dialysis and the need for AVF closure 59 . In our study, such a thesis was not proven. Among other things, Schier et al. consider that there is a link between faster need for "closure" of AVF with faster flow rate and reduced need for "closur" of AVF with slower blood flow 59 . In our study, as noted above, no data were available on the rate of blood flow through the AVF. The median time to AVF thrombosis or ligation in our participants was 2 years, while in 12 patients who experienced thrombosis during the first year, AVF usually stopped functioning as early as the first month. In a study by Schier et al., the median time to thrombosis or ligation of AVF was 2 years and 6 months, consistent with our result 59 . Previous studies on the fate of AVF have been in the form of case reports or have been conducted in a small number of patients. This study, as well as the study conducted by Schier et al., may show success in the closure or ligation of AVF to prevent the development of cardiac overload, especially in individuals with rapid blood flow through AVF. An individual decision to close or not to close AVF must include all relevant factors, especially the function of the transplanted kidney, as well as the ability to create a new vascular approach in the event of graft rejection. Diseases such as anemia and hypertension can mask the symptoms of heart failure, therefore echocardiographic monitoring as well as other non-invasive procedures may be useful for timely intervention in the event of a potential development of cardiac overload caused by rapid flow through AVF 59 . In our patients, the assessment of heart overload caused by AVF has not been echocardiographically demonstrated.
concluSion Based on the results of the study, the following conclusions can be drawn: AVF before TX had 78% of patients, AVF is currently functioning in 39.84% of patients, and AVF was ligated or thrombosed in 38.22% of patients. Furthermore, the most common cause of AVF ligation in our study was cardiac overload, the time to thrombosis or ligation was median 2 years after TX, and if thrombosis occurred in the first posttransplant year, then it occurred at the median time 1 month after TX. And finally, AVF thrombosis or ligation was more common in women, and the fate of AVF after renal TX was not related to patient age.
In conclusion, AVF after renal TX often becomes dysfunctional, following spontaneous thrombosis or surgical ligation most commonly indicated by cardiac overload. 
